Opioid study reveals how painkillers affect mood before surgery
NCT ID NCT05639712
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study in Norway looked at how opioids like morphine, oxycodone, and fentanyl affect patients' mood and pain right before surgery. Over 1,000 healthy adults scheduled for day surgery answered questions about anxiety, relaxation, and pain after receiving a small dose of opioid or a placebo. The study also tracked how much pain medication patients needed after surgery and what factors predicted long-term opioid use or persistent pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Morphine, oxycodone, fentanyl, and placebo (saline)
- What this could lead to
- If successful, this could help doctors understand how opioids affect mood and pain, potentially leading to better pain management after surgery.
- What could go wrong
- This is a completed Phase 4 study focused on observation and short-term effects, not a treatment trial. Results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
1,020 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Health status ASA1 (American Society of Anesthesiologists physical status) or ASA2 as categorised by a medical doctor at the hospital based on medical history, physical examination, laboratory test etc. unrelated to the current study. ASA1 and ASA2 (ASA1 is defined as "Healthy, non-smoking, no or minimal alcohol use" and ASA2 is defined as "Mild diseases only without substantive functional limitations). Being eligible for day surgery means participants are overtly healthy as determined by clinical staff. * The participant is considered as eligible for the use of fentanyl, morphine and oxycodone by a medical doctor at the hospital, based on an overall assessment of the psychiatric and somatic condition, used medical drugs, regarding possible interactions and contraindications for the use of the study medicaments. * Body weight and body mass index (BMI) within the range 18-35 kg/m2 (inclusive). * Capable of giving signed informed consent as which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol. * Having good verbal communication skills in Norwegian. * Patients undergoing planned day surgery with general anesthesia (outpatient sample). * Orthopedic, rectal, gynecological, hand and foot surgery, and minor vascular procedures. * Inpatients undergoing planned gynecological and orthopedic surgery. * Hysterectomy, laparoscopic ovariectomy, lumbal herniotomy and other related procedures. * Minor gastrointestinal surgery Exclusion Criteria: 1. Known allergic reactions to morphine, oxycodone,or fentanyl. Known allergic reactions to any of the incredients described in the SPC, pt 6.1. 2. Severe chronic obstructive lung disease, 3. Cor pulmonale, 4. Severe bronchial asthma, 5. Severe respiratory failure with hypoxemia and hypercapnia 6. Moderate to severe hepatic impairment, 7. Moderate to severe kidney failure 8. Acute abdomen 9. Increased brain pressure 10. Head trauma 11. Use of MAO blockers in the last two weeks 12. Hypovolemia 13. Hypotension 14. Myasthenia gravis 15. Any other health status not corresponding to ASA1 or ASA2. This includes patients with severe disease burden, major psychiatric disorders that could interfere with the procedures and communication. 16. Pregnancy. Women of childbearing potential defined as all premenopausal female (a postmenopausal state is defined as no menses for 12 months without an alternative medical cause) will be asked if they are pregnant. 17. Breastfeeding women. 18. Illegal drugs use like opioids, cocaine and amphetamine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Affective symptoms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harald Lenz
Oslo, Oslo, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Prisons as HIV prevention hubs: can opioid treatment reach more people behind bars?
- Which nerve block keeps lungs stronger after chest surgery?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Can mindfulness curb opioid use after injury?
- Can mindfulness after injury curb opioid dependence?